Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−584,192−100.0%Sold outHolders
Q1 2026584,192$23.5M<0.1%+26,601+4.8%AddedHolders
Q4 2025557,591$14.0M<0.1%−414,883−42.7%ReducedHolders
Q3 2025972,474$22.0M<0.1%−325,985−25.1%ReducedHolders
Q2 20251,298,459$22.5M<0.1%+187,750+16.9%AddedHolders
Q1 20251,110,709$24.3M<0.1%+259,886+30.5%AddedHolders
Q4 2024850,823$27.1M<0.1%+691,123+432.8%AddedHolders
Q3 2024159,700$4.61M<0.1%+55,282+52.9%AddedHolders
Q2 2024104,418$4.01M<0.1%+52,792+102.3%AddedHolders
Q1 202451,626$3.03M<0.1%−115,862−69.2%ReducedHolders
Q4 2023167,488$10.0M<0.1%−68,867−29.1%ReducedHolders
Q3 2023236,355$8.99M<0.1%+177,694+302.9%AddedHolders
Q2 202358,661$5.34M<0.1%−57,969−49.7%ReducedHolders
Q1 2023116,630$7.69M<0.1%+80,434+222.2%AddedHolders
Q4 202236,196$1.87M<0.1%−79,166−68.6%ReducedHolders
Q3 2022115,362$7.88M<0.1%+95,294+474.9%AddedHolders
Q2 202220,068$907.5K<0.1%+13,717+216.0%AddedHolders
Q1 20226,351$322.7K<0.1%−8,586−57.5%ReducedHolders
Q4 202114,937$706.2K<0.1%+3,497+30.6%AddedHolders
Q3 202111,440$377.1K<0.1%+9,137+396.7%AddedHolders
Q2 20212,303$145.6K<0.1%−5,199−69.3%ReducedHolders
Q1 20217,502$321.9K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.